Detecting Fentanyl Analogs in Urine Using Precursor Ion Scan Mode.

Area of Science:

• Forensic Toxicology
• Analytical Chemistry
• Pharmacology

Background:

• The widespread opioid crisis necessitates enhanced detection of synthetic opioids like fentanyl and its analogs in clinical settings.
• Existing urine drug testing methods (immunoassays, targeted LC-MS/MS) lack the breadth to identify diverse fentanyl analogs.
• There is a critical need for broader screening capabilities to address the evolving landscape of novel psychoactive substances.

Purpose of the Study:

• To develop and validate a novel precursor ion scan method for the semi-targeted detection of structurally related fentanyl analogs in urine.
• To assess the capability of this method in identifying a range of fentanyl analogs beyond those typically screened.
• To provide a proof-of-principle for an improved analytical approach in forensic toxicology.

Main Methods:

• Development of a precursor ion scan method utilizing tandem mass spectrometry.
• Data acquisition focused on precursor ions (250-400 Da) that fragment to characteristic product ions (m/z=188 and m/z=105).
• Analysis of 102 residual urine specimens and 30 contrived urine samples spiked with various fentanyl analogs.

Main Results:

• Successfully identified fentanyl, acetylfentanyl, and acrylfentanyl in clinical urine specimens.
• Detected additional analogs including furanylfentanyl, butryrlfentanyl, 4-fluroisobutrylfentanyl, and despropionylfentanyl in spiked samples.
• Achieved high accuracy (83-100%) for the identification of these diverse fentanyl analogs.

Conclusions:

• The developed precursor ion scan method offers enhanced capabilities for detecting a wider spectrum of fentanyl analogs in urine.
• This approach represents a significant advancement over current clinical urine drug testing limitations for novel synthetic opioids.
• The method shows promise for improving forensic toxicology and public health surveillance related to the opioid crisis.